RNA editing at specific sites is shaped by a combination of cis-acting sequence features and trans-acting protein factors. The most common form in mammals, adenosine-to-inosine (A-to-I) editing, is catalyzed by the ADAR family of enzymes, whose activity depends on both the local RNA structure and the cellular context. Research by David J. Levanon The Hebrew University of Jerusalem showed that many human editing events cluster in repetitive Alu elements, emphasizing how species-specific genomic architecture drives site frequency. This explains why primates show particularly high editing in noncoding regions.
Structural and sequence determinants
A target adenosine must usually reside within a double-stranded RNA (dsRNA) region to be accessible to ADARs. Complementary sequences such as editing complementary sequences (ECS) in nearby introns or exons form the dsRNA substrate; the length, stability, and base-pairing pattern of that duplex strongly influence editing rates. Immediate flanking nucleotides also bias enzyme recognition: certain sequence contexts increase catalytic efficiency, while mismatches or bulges can suppress editing at a specific adenosine. Foundational biochemical work by Brenda L. Bass University of Utah elucidated the importance of dsRNA-binding domains in directing ADAR specificity, linking protein structure to site choice.Genetic variation and trans factors
Genetic variation alters editing both in cis—single-nucleotide polymorphisms that disrupt pairing and change local structure—and in trans—variants that modulate expression, splicing, or activity of ADAR enzymes. The human genome encodes ADAR1 and ADAR2 (ADAR and ADARB1 genes), with ADAR3 expressed in brain but showing limited catalytic activity; relative expression levels across tissues create site-specific editing landscapes. Regulatory variants and expression quantitative trait loci (eQTLs) affecting ADAR genes or RNA-binding cofactors can therefore act as editing quantitative trait loci (edQTLs).Consequences extend from transcript recoding, which can alter protein function in the nervous system, to innate immune regulation: robust editing of endogenous dsRNA prevents inappropriate activation of cytosolic sensors. When editing is perturbed by genetic changes or dysregulated expression, the result can be altered neuronal physiology or immune signaling, with population and species differences reflecting cultural and territorial genomic histories—for example, Alu-rich genomes in humans compared with other mammals. Understanding these genetic determinants is critical for interpreting variation in editing across individuals and for targeting editing therapeutically.